Diclofenac release from eudragit-containing matrices and effects of thermal treatment.
Ethyl acrylate-methyl methacrylate copolymer (Eudragit NE40D) was evaluated as matrix material for preparing controlled-release tablets of diclofenac sodium. Drug release could be modified in a predictable manner by varying the Eudragit NE40D content, but was pH dependent, being markedly reduced at lower pH. This could be attributed to the low solubility of the drug at these pH values. Thermal treatment of the tablets at 60 degrees C was also found to affect the rate of drug release, which was found to decrease with an increase in the treatment duration, but could be stabilized after 96 hr of treatment. This was also associated with a corresponding increase in the tablet tensile strength. However, treatment of the granules for 5 hr prior to compaction into tablets could shorten the stabilizing time of the drug release to 48 hr and that of the tensile strength to 24 hr. The effect of thermal treatment may be ascribed to better coalescence of the Eudragit particles to form a fine network, resulting in matrix of higher tortuosity and lower porosity.
Billa
N
N
School of Pharmaceutical Sciences, University of Science Malaysia, 11800, Penang, Malaysia.
Yuen
K H
KH
Peh
K K
KK
D004008:Diclofenac / Q000737:chemistry*; D004339:Drug Compounding; D004355:Drug Stability; D005079:Excipients / Q000737:chemistry*; D006361:Heating; D006863:Hydrogen-Ion Concentration; D008689:Methacrylates / Q000737:chemistry*; D011108:Polymers / Q000737:chemistry*; D016062:Porosity; D012995:Solubility; D013607:Tablets; D013718:Tensile Strength; D013997:Time Factors
C477853:Eudragit NE 30-D; D005079:Excipients; D008689:Methacrylates; D011108:Polymers; D013607:Tablets; D004008:Diclofenac